See MBX Biosciences Common Stock's analyst price targets ($89) vs the current share price.
Get informed when a big investor buys or sells
+ Follow$53.63
3 analysts in the last 4 months
High: $90 | Low: $88
No recommendations in the last 4 months.
As of the most recent data, MBX shows a target price of $89. Scroll down for historical charts and peer comparison views.
If MBX Biosciences Common Stock moved to the average analyst target of $89, shares would be roughly 65.3% higher than $53.63. Treat that as a sentiment and modeling checkpoint rather than a precise forecast, and weigh it against your own view of MBX Biosciences Common Stock's earnings trajectory.
Besides this target price page, Stockcircle has MBX Biosciences Common Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect target price (currently $89) with ownership activity and broader fundamentals.
MBX Biosciences Common Stock's target price is $89; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.